News

ASCO 2013: Breast cancer research highlights

Publish date: June 5, 2013

 

Dr. William Gradishar and Dr. Hope Rugo, Associate Editors of The Oncology Report, give their perspectives on how new breast cancer research presented at ASCO 2013 should affect clinical practice.

Recommended Reading

Maintenance pazopanib delays progression of advanced ovarian cancer
MDedge ObGyn
Cervical cancer screening with acetic acid saves lives
MDedge ObGyn
Bevacizumab plus chemotherapy extends cervical cancer survival
MDedge ObGyn
10 years of tamoxifen halves risk of death from breast cancer
MDedge ObGyn
Which paclitaxel schedule works best for breast cancer?
MDedge ObGyn
Palbociclib continues on fast track to potential FDA approval
MDedge ObGyn
Study confirms benefits of 10 years of tamoxifen
MDedge ObGyn
Weekly adjuvant paclitaxel for breast cancer has less toxicity
MDedge ObGyn
Bremelanotide improves female sexual dysfunction
MDedge ObGyn
Teen birth rate down almost 50% since 1991
MDedge ObGyn